Although, enhanced expression of activating transcription factor 3 has been reported to play a role in diabetic angiopathy[80], in stress-induced beta cell dysfunction[83,84] and hepatic LDL receptor down-regulation[85,86], its cardiac role in metabolic syndrome has not been implicated yet. This evidence concerns the gene ATF3 and diabetic peripheral angiopathy.